Showing 4291-4300 of 8897 results for "".
- FDA Accepts Aclaris Therapeutics' NDA for Topical Treatment of Seborrheic Keratosishttps://practicaldermatology.com/news/fda-accepts-aclaris-therapeutics-nda-for-topical-treatment-of-seborrheic-keratosis/2458188/The FDA has accepted Aclaris Therapeutics' New Drug Application (NDA) for A-101 40% topical solution, an investigational drug for the potential treatment of seborrheic keratosis (SK). The NDA acceptance by the FDA in its 74-day letter indicates that the application is sufficiently complete to
- DerMend's New Line Takes On Mature Skin Issueshttps://practicaldermatology.com/news/dermends-new-line-takes-on-mature-skin-issues/2458190/DerMend® is launching DerMend® Mature Skin Solutions. The new product line features DerMend®Fragile Skin Moisturizing Formula, DerMend® Moisturizing Anti-Itch Lotion and DerMend® Moisturizing Bruise Formu
- Valeant Appoints New Dermatology and Corporate Communications Leadership Membershttps://practicaldermatology.com/news/valeant-appoints-new-dermatology-and-corporate-communications-leadership-members/2458192/Valeant Pharmaceuticals International, Inc. added new members to the dermatology leadership team—Michael McMyne is the new Vice President of Sales and Stacey Williams is the new Vice President of Marketing. Additionally, the comp
- LEO Pharma U.S. Welcomes Judit H. Nyirady as Vice President of Medical Strategy & Scientific Affairshttps://practicaldermatology.com/news/leo-pharma-us-welcomes-judit-h-nyirady-as-vice-president-of-medical-strategy-scientific-affairs/2458194/Judit H. Nyirady, MD, MBA, is the new Vice President of Medical Strategy & Scientific Affairs at LEO Pharma Inc. In this role, she will be responsible for the medical and scientific affairs strategies for LEO Pharma in the United States, as well
- Pfizer Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for XELJANZ® (tofacitinib citrate) for the Treatment of Adult Patients with Active Psoriatic Arthritishttps://practicaldermatology.com/news/pfizer-announces-us-fda-filing-acceptance-of-supplemental-new-drug-application-for-xeljanz-tofacitinib-citrate-for-the-treatment-of-adult-patients-wit/2458195/(via BusinessWire) Pfizer Inc. announced today that the United States Food and Drug Administration (FDA) has accepted for rev
- Nutrition for Healing Introduces MEND Cosmetic to Support Improved Healing & Recovery From Cosmetic Surgeryhttps://practicaldermatology.com/news/nutrition-for-healing-introduces-mend-cosmetic-to-support-improved-healing-recovery-from-cosmetic-surgery/2458201/Nutrition For Healing LLC launched its new MEND Cosmetic, which is now available through cosmetic surgeons worldwide. The all natural formula, a blend of clinically researched, proven ingredients designed specifically to support healing from cosmetic surgery,
- Is Widespread Vitamin D Deficiency Due to Chronic Disease, Sunscreen Use? New Study Says Yeshttps://practicaldermatology.com/news/is-widespread-vitamin-d-deficiency-due-to-chronic-disease-sunscreen-use-new-study-says-yes/2458205/Nearly 1 billion people worldwide may have deficient or insufficient levels of vitamin D due to chronic disease and inadequate sun exposure related to sunscreen use, according to a study in the Journal of the American Osteopathic Association.
- Non-Invasive Pigmented Lesion Assay Almost Doubles Biopsy Specificityhttps://practicaldermatology.com/news/use-of-non-invasive-pigmented-lesion-assay-almost-doubles-biopsy-specificity/2458209/Dermatologists who incorporate Dermtech’s noninvasive pigmented lesion assay will biopsy fewer benign pigmented skin lesions and miss fewer melanomas, according to a new study in JAMA Dermatology
- Kourtney Kardashian's Fave Skincare Brand Rolls Out New Body Oil Collectionhttps://practicaldermatology.com/news/kourtney-kardashians-fave-skincare-brand-rolls-out-new-body-oil-collection/2458212/Manuka Doctor is launching their newest body oil collection --The Manuka Doctor 24K Gold & Manuka Honey. The brand, which boasts Kourtney Kardashian as their global ambassador, is rolling out the new collection in late April 2017. The bo
- ThermiGen, an Almirall company, Names Vladimir Paul-Blanc President & General Managerhttps://practicaldermatology.com/news/thermigen-an-almirall-company-names-vladimir-paul-blanc-president-general-manager/2458219/Vladimir Paul-Blanc has been named President & General Manager of ThermiGen, LLC, starting May 1. He will report directly to the Executive Vice-president of Commercial Strategy of Almirall, Alfonso Ugarte, and he will be responsible for all general management responsibilities for the Thermi b